Blood Pressure Drug Recalled After Oxycodone Found on Production Line
Drug manufacturer KVK-Tech, Inc. has issued a voluntary recall of blood pressure drug betaxolol after oxycodone was discovered on the production line. The recall notice, published Sept. 29, 2023 by the U.S. Food and Drug Administration (FDA), says the precautionary measure is being taken following the discovery of a single 5 mg Oxycodone Hydrogen Chloride […]
Pfizer Will Charge Patients $1,390 for COVID Anti-Viral Paxlovid
Pfizer, Inc. plans to charge consumers more than double the price charged to the U.S. government for its COVID-19 anti-viral drug nirmatrelvir-ritonavir, sold under the brand name Paxlovid. A five-day course of the drug to treat COVID will soon cost patients $1,390. According to researchers, it costs Pfizer $13 to manufacture the supply of pills […]
U.S. Vaccine Industry Harvesting Blood from Horseshoe Crabs
For many decades, the blue colored blood from horseshoe crabs has been harvested for purposes of medical research and for quality control and safety testing in vaccines, prosthetics and intravenous drugs. Their eggs are also a staple food for a shorebird bird known as the red knot, which is listed as threatened under the Endangered […]
Novavax to Receive $350 Million for Cancelled COVID Vaccine Orders in Canada
According to a securities filing with the U.S. Securities and Exchange Commission (SEC) by Novavax Inc. of Gaithersburg, Maryland on June 30, 2023, the government of Canada will pay the company $349.6 million to settle the forfeiting of doses of its Nuvaxovid recombinant protein COVID-19 vaccine previously ordered and scheduled for delivery.1 2 Nuvaxvoid was […]
FDA Panel Endorses New Alzheimer’s Drug After Accelerated Approval
The newest Alzheimer’s drug is on its way for full regulatory approval after a U.S. Food and Drug Administration (FDA) advisory panel voted that the drug was beneficial in slowing cognitive decline. The drug is expected to be fully approved by July 6, 2023.1 In clinical trials the drug, known as lecanemab, demonstrated a 27 […]
Global Pediatric Vaccines Market to Exceed $69 Billion by 2030
A report released by Coherent Market Insights showed that pediatric vaccines market will surpass $69.482 billion by 2030.1 The main pharmaceutical companies in the global market for pediatric vaccines include Bharat Biotech, Emergent BioSolutions, GSK, Indian Immunologicals, Merck, Panacea Biotec, Pfizer, Sanofi, Serum Institute and Zydus Cadila.2 Pediatric Vaccine Approvals by Governments Will Drive Vaccine […]